Coya Therapeutics, Inc. (COYA), a company focused to enhance regulatory T cell function, said on Monday that it has promoted its Chief Business Officer, Arun Swaminathan, as Chief Executive Officer with effect from November 1.
He will succeed, Howard Berman, who will continue to serve in the capacity of Executive Chair.
Prior to joining Coya as its Chief Business Officer, a role he has served in since April 2023, he had executed significant commercial transactions at Alteogen Inc. and Actinium Pharmaceuticals.
Swaminathan was also the founder and CEO of Lynkogen, Inc., a company developing GLP-1 fusion proteins.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.